PMC:7289100 / 9347-9546 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T127","span":{"begin":12,"end":34},"obj":"Disease"},{"id":"T128","span":{"begin":36,"end":39},"obj":"Disease"},{"id":"T131","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"T132","span":{"begin":63,"end":66},"obj":"Disease"},{"id":"T135","span":{"begin":127,"end":161},"obj":"Disease"},{"id":"T136","span":{"begin":138,"end":161},"obj":"Disease"}],"attributes":[{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0005851"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0007947"},{"id":"A129","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0019202"},{"id":"A130","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0005851"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0007947"},{"id":"A133","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0019202"},{"id":"A134","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0005851"},{"id":"A135","pred":"mondo_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/MONDO_0016493"},{"id":"A136","pred":"mondo_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"e [38].\n\n5 Miller Fisher syndrome (MFS) secondary to COVID-19\nMFS is a rare, acquired disease that is considered to be a mild variant of Guillain-Barré syndrome, and is observed in about 5% of all c"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T88","span":{"begin":70,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T89","span":{"begin":120,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"e [38].\n\n5 Miller Fisher syndrome (MFS) secondary to COVID-19\nMFS is a rare, acquired disease that is considered to be a mild variant of Guillain-Barré syndrome, and is observed in about 5% of all c"}

{"project":"LitCovid-sentences","denotations":[{"id":"T57","span":{"begin":9,"end":62},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e [38].\n\n5 Miller Fisher syndrome (MFS) secondary to COVID-19\nMFS is a rare, acquired disease that is considered to be a mild variant of Guillain-Barré syndrome, and is observed in about 5% of all c"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T168","span":{"begin":54,"end":62},"obj":"SP_7"},{"id":"T97252","span":{"begin":54,"end":62},"obj":"SP_7"}],"text":"e [38].\n\n5 Miller Fisher syndrome (MFS) secondary to COVID-19\nMFS is a rare, acquired disease that is considered to be a mild variant of Guillain-Barré syndrome, and is observed in about 5% of all c"}

{"project":"LitCovid-PubTator","denotations":[{"id":"312","span":{"begin":36,"end":39},"obj":"Disease"},{"id":"313","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"362","span":{"begin":63,"end":66},"obj":"Disease"}],"attributes":[{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"MESH:D008382"},{"id":"A313","pred":"tao:has_database_id","subj":"313","obj":"MESH:C000657245"},{"id":"A362","pred":"tao:has_database_id","subj":"362","obj":"MESH:D008382"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e [38].\n\n5 Miller Fisher syndrome (MFS) secondary to COVID-19\nMFS is a rare, acquired disease that is considered to be a mild variant of Guillain-Barré syndrome, and is observed in about 5% of all c"}

{"project":"2_test","denotations":[{"id":"32535093-32246917-4828863","span":{"begin":3,"end":5},"obj":"32246917"}],"text":"e [38].\n\n5 Miller Fisher syndrome (MFS) secondary to COVID-19\nMFS is a rare, acquired disease that is considered to be a mild variant of Guillain-Barré syndrome, and is observed in about 5% of all c"}